Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Sub Analysis by Regions
Global Heart · 12.11.2026 · 21 (1) · 81
DOI: 10.5334/gh.1600 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Heart, online erschienen am 12.11.2026. Verfasst von Fernando Wyss und 22 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Services and Technology of Guatemala, Guatemala. Hauptthemen laut MEDLINE: Pneumococcal Vaccines, Influenza Vaccines, Cardiovascular Diseases, Vaccination. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
In Latin America, the mortality rate from influenza and pneumococcal disease has increased in recent years. Several challenges limit the implementation of vaccination strategies. These factors contribute to lower-than-expected immunization rates in Latin America.
Objective
The objective of this sub-analysis of the Inter-American Registry of Influenza and Pneumococcal Vaccination (CorVacc) is to determine vaccination rates and analyze the factors that influence the North – Central America and Carribean Spanish Speaking (NCC); Andean region (AR) and South Cone (SCR).
Methods
A cross-sectional survey of the general population was conducted in 19 Latin American countries. Adults aged 18 and older completed a 34-question online survey. Data were grouped into seven categories: demographic, socioeconomic, and non-demographic. Multivariate logistic regression comparisons were performed between regions to assess the association between vaccination rates and their explanatory variables.
Results
Influenza, Pneumococcus and ≥3 doses of COVID-19 vaccination was received by 4,126 (45.18%) CAC, 3,576 (50, 13%) AR and 3,024 (62, 99%) SC; 5,904 (65, 09%) CAC, 5,162 (68, 9%) AR and 3,486 (72, 61%) SC; and 6,266 (68, 61%) CAC, 6,001 (80, 09%) AR and 2,892 (79, 99%), respectively. No association was detected between the regions and the likelihood of receiving the influenza vaccine: AR OR 0.94 (95% CI 0.84–1, 06; p = 0.33), CAC OR 0.81 (CI 0.80–1, 00; p = 0.053). On the contrary, a positive association was detected with Streptococcus pneumoniae vaccination: AR OR 1.12 (CI 1, 01–1, 24; p = 0.032), CAC OR 1.33 (CI 1, 20–1, 47; p < 0.001). A negative association was observed in CAC with COVID-19 ≥ 3 doses vaccination: OR 0.56 (CI 0, 65; p = 0.032; p < 0.001). Social, economic and confidence barriers were identified, but cardiovascular risk factors and comorbidities were not significantly associated with lower vaccination rates.
Conclusions
Social, economic, and cultural, but not cardiovascular risk factor or disease variables in Latin American region could explain the lower-than-expected rates of vaccination and the differences observed between regions in vaccination frequencies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Services and Technology of Guatemala, Guatemala.
- Instituto de Cardiología del Sanatorio Británico, Rosario, Argentina.
- Hospital Italiano de la Plata, La Plata, Argentina.
- Congenital Heart Disease Department, National Medical Center 21st. Century, México.
- Department of Cardiology, Instituto Guatemalteco de Seguridad Social (IGSS), Guatemala, Guatemala.
- Hospital Metropolitano de Quito, Universidad Internacional del Ecuador, Quito, Ecuador.
ORCID-Profile: Fernando Wyss, Daniel Piskorz, Ricardo Lopez-Santi, Lucelli Yañez Gutiérrez, Horacio Márquez-Gonzales, Fabio Enrique Parada, Vladimir Ullauri, Ana Munera Echeverri, Juan Esteban Gómez, Osiris Valdez, Máxima Méndez, Claudia Almonte, Carlos Ponte-Negretti, María Alayde Mendoça Rivera, Iván Romero Rivera, Raúl Villar, Jorge Alberto Rivera, Dulman Pineda de Paz, Ana Isabel Barrientos, Gonzalo Piskorz, Pilar Lopez-Santi
Zitieren
APA
Wyss, F., Piskorz, D., Lopez-Santi, R., Gutiérrez, L. Y., Márquez-Gonzales, H., Parada, F. E., Ullauri, V., Echeverri, A. M., Gómez, J. E., Valdez, O., Méndez, M., Almonte, C., Ponte-Negretti, C., Rivera, M. A. M., Rivera, I. R., Villar, R., Rivera, J. A., de Paz, D. P., Barrientos, A. I., …, & CorVacc study investigators. Cardiovascular Prevention Council (SIAC-PREVENT) of the Inter-American Society of Cardiology (SIAC) (2026). Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Sub Analysis by Regions. Global Heart, 21(1), 81. https://doi.org/10.5334/gh.1600
Vancouver
Wyss F, Piskorz D, Lopez-Santi R, Gutiérrez LY, Márquez-Gonzales H, Parada FE, et al. Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Sub Analysis by Regions. Global Heart. 2026;21(1):81. doi:10.5334/gh.1600
BibTeX
@article{Wyss2026,
author = {Wyss, Fernando and Piskorz, Daniel and Lopez-Santi, Ricardo and Gutiérrez, Lucelli Yañez and Márquez-Gonzales, Horacio and Parada, Fabio Enrique and Ullauri, Vladimir and Echeverri, Ana Munera and Gómez, Juan Esteban and Valdez, Osiris and Méndez, Máxima and Almonte, Claudia and Ponte-Negretti, Carlos and Rivera, María Alayde Mendoça and Rivera, Iván Romero and Villar, Raúl and Rivera, Jorge Alberto and de Paz, Dulman Pineda and Barrientos, Ana Isabel and Jordan, Edmundo and Piskorz, Gonzalo and Lopez-Santi, Pilar and CorVacc study investigators. Cardiovascular Prevention Council (SIAC-PREVENT) of the Inter-American Society of Cardiology (SIAC), CorVacc study investigators. Cardiovascular Prevention Council (SIAC-PREVENT) of the Inter-American Society of Cardiology (SIAC)},
title = {Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Sub Analysis by Regions},
journal = {Global Heart},
year = {2026},
volume = {21},
number = {1},
pages = {81},
doi = {10.5334/gh.1600}
}
EUVIMED